Squadron Capital Management LLC: 13F holdings
CIK 20507092026Q2
| Positions | 38 |
|---|---|
| Reported value | $322.2m |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| RELMADA THERAPEUTICS INC | 7,350,000 | $50.9m | 15.8% |
| C4 THERAPEUTICS INC | 7,200,000 | $33.6m | 10.4% |
| COGT COGENT BIOSCIENCES INC | 865,000 | $33.5m | 10.4% |
| KOD KODIAK SCIENCES INC | 500,000 | $19.5m | 6.0% |
| RLAY RELAY THERAPEUTICS INC | 970,000 | $18.1m | 5.6% |
| ZNTL ZENTALIS PHARMACEUTICALS INC | 3,700,000 | $17.9m | 5.6% |
| EWTX EDGEWISE THERAPEUTICS INC | 290,000 | $11.8m | 3.7% |
| MAZE THERAPEUTICS INC | 335,000 | $10.0m | 3.1% |
| INVENTIVA SA | 2,435,000 | $9.2m | 2.9% |
| ADLAI NORTYE LTD | 764,876 | $8.8m | 2.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2050709")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.